Table 2.
Deaths avoided by strategy (2010) and cumulative deaths avoided 2005–2020
Deaths 2010 | Deaths Avoided relative to 2005 levels, 2010 | Cumulative Deaths Avoided, 2005–2020 | ||
---|---|---|---|---|
Stabilization and continuation of 2005 levels in risk factors, screening, and chemotherapy | Women | 23,783 | N/A | N/A |
Men | 24,965 | N/A | N/A | |
Total | 48,748 | N/A | N/A | |
Strategy | ||||
Simultaneous interventions* | Women | 21,972 | 1,811 | 50,753 |
Men | 23,190 | 1,775 | 50,600 | |
Total | 45,162 | 3,586 | 101,353 | |
Risk factors improve | Women | 23,623 | 160 | 8,364 |
Men | 24,830 | 135 | 10,793 | |
Total | 48,453 | 295 | 19,158 | |
Screening rates increase | Women | 22,800 | 983 | 33,864 |
Men | 23,874 | 1,091 | 31,828 | |
Total | 46,674 | 2,074 | 65,692 | |
Chemotherapy use increases | Women | 23,196 | 587 | 10,205 |
Men | 24,236 | 729 | 11,386 | |
Total | 47,432 | 1,316 | 21,591 |
N/A= not applicable.
The simulation of the benefits from the implementation of simultaneous interventions allows for a synergistic effect among strategies that results in a different number of deaths than would be achieved with each strategy implemented individually.